Marcadores Inmunohistoquímicos en el Diagnóstico Diferencial de Melanoma y Nevos en Humanos

Tweet about this on TwitterShare on FacebookEmail this to someoneShare on Google+

Nelson Quilaqueo; Felipe Navarrete; Cristian Sandoval; Ignacio Roa; Mario Pellón & Marco Paredes


: Immunohistochemistry allows in situ detection of cell and extracellular components through specific antibodies. The objective was to compare the immunohistochemical expression patterns of the S-100, HMB-45 and MART-1 proteins for differential diagnosis of malignant melanoma and melanocytic nevus in human skin biopsies. Thirty-nine biopsies of human tissue were used. They were divided into two groups: 19 in malignant melanoma and 20 in melanocytic nevi. Next, the samples were fixed with paraformaldehyde and processed following the protocol for inclusion. Then, immunohistochemical staining was performed. Finally, the histological and qualitative analysis of the samples was carried out. S-100, HMB-45, and MART-1 markers showed positive immunoreaction in melanoma biopsies. HMB-45 marker was generally present with weaker expression than S-100 and MART-1 in melanocytic nevus biopsies. No expression pattern was observed which specifically associates one or more markers with some types of histopathological diagnosis. Immunohistochemistry is fundamental in differential diagnosis of melanomas and melanocytic nevi. However, there is no antibody or set of antibodies which allows unequivocal diagnosis between melanoma and nevus. It is therefore necessary to analyze with care the expression pattern and location of the lesion using standard morphological characteristics.

KEY WORDS: Antigen antibody complex; Immunohistochemistry; Immunohistochemical markers; Pathology.

Como citar este artículo

QUILAQUEO, N.; NAVARRETE, F.; SANDOVAL, C.; ROA, I.; PELLÓN, M. & PAREDES, M. Immunohistochemical markers in the differential diagnosis of melanoma and nevus in humans. Int. J. Morphol., 39(5):1509-1515, 2021.